October 15, 2019 / 6:24 AM / a month ago

Indivior raises full-year revenue forecast on Suboxone strength

Oct 15 (Reuters) - Indivior PLC on Tuesday raised its full-year revenue forecast, banking on the strength of its opioid-addiction treatment Suboxone.

The company said it now expects full-year net revenue to be in the range of $750 million to $790 million, compared with the prior forecast of $670 million to $720 million.

The company also said it expects 2019 net income in the range of $160 million to $190 million. (Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Subhranshu Sahu)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below